Found 49 matching trials
IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia PHASE2 This is an open-label, single-arm, Phase 2 study to evaluate the efficacy a...
Show More Location
The First Hospital of Jilin University
Learn More & Join Trial
Anti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple Myeloma PHASE1 This phase I trial studies the side effects and best dose of BCMA CART cell...
Show More Location
Shenzhen Second People's Hospital,The first affiliated hospital of Shenzhen University
Learn More & Join Trial
Clinical Study on the Safety and Efficacy of PID23 Injection in Patients With Relapsed/Refractory Acute Leukemia EARLY_PHASE1 Relapsed or refractory acute leukemia (R/R AL) is a life-threatening blood ...
Show More Location
Department of Hematology, Zhujiang Hospital, Southern Medical University
Learn More & Join Trial
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases PHASE1 This is an open, single-arm, clinical study to evaluate the efficacy and sa...
Show More Location
District One Hospital
Learn More & Join Trial
Autologous CAR-T Cell Therapy for Refractory and Relapsing Ulcerative Colitis: A Single-Center Exploratory Study EARLY_PHASE1 A Single-Center, Open-Label, Single-Arm Exploratory Clinical Study on the U...
Show More Location
Foresea Life Insurance Guangzhou General Hospital
Learn More & Join Trial
Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease PHASE2 The goal of this clinical trial is to test the safety and potential benefit...
Show More Location
Department of Rheumatology and Immunology, the First Medical Center, Chinese PLA General Hospital
Learn More & Join Trial
Targeting CD19 and BCMA CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Multiple Myeloma PHASE1 Evaluation the safety,tolerability, preliminary efficacy,and PK/PD of KQ-20...
Show More Location
Hematology Department of ShanXi Cancer Hospital
Learn More & Join Trial
RN1201 Injection in Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma PHASE1 This is a single-arm, dose-escalation exploratory study evaluating the safe...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C)in Patients With Refractory Primary Immune Thrombocytopenia EARLY_PHASE1 This is an investigator-initiated trial to evaluate the safety and efficacy...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Restoration of Immunity to Vaccine Preventable Diseases After CART-T Cell Therapy N/A The goal of this observational study is to learn about vaccine immunity in ...
Show More Location
University Hospital Bern
Learn More & Join Trial